Old Web
English
Sign In
Acemap
>
authorDetail
>
Helen Dignum
Helen Dignum
Queen Alexandra Hospital
Medicine
Immunology
Odds ratio
Survival rate
Cytarabine
4
Papers
185
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia
2015
Blood
Michael Dennis
Nigel H. Russell
Robert Kerrin Hills
Claire Hemmaway
Nicki Panoskaltsis
Mary Frances McMullin
Lars Kjeldsen
Helen Dignum
Ian F. Thomas
Richard E. Clark
Don Milligan
Alan Kenneth Burnett
Show All
Source
Cite
Save
Citations (43)
Observations On Eosinophil Ifiltrates in The Bone Marrow Of Patients With Multiple Myeloma. Clinicopathological Correlates
2013
Blood
Tanya Cranfield
Robert Corser
Helen Dignum
Christopher James
Mary Ganczakowski
Show All
Source
Cite
Save
Citations (0)
The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison
2013
Leukemia
Alan Kenneth Burnett
Robert Kerrin Hills
A Hunter
D Milligan
William J. Kell
Keith Wheatley
John Liu Yin
Mary Frances McMullin
Helen Dignum
Derrick John Bowen
Nicholas H. Russell
Show All
Source
Cite
Save
Citations (135)
The Addition of Gemtuzumab Ozogamicin to Low Dose Ara-C Improves Remission Rates but Not Survival: Results of the UK LRF AML14 and NCRI AML16 “Pick a Winner” Comparison
2010
Blood
Alan Kenneth Burnett
Robert Kerrin Hills
Ann Hunter
Donald Milligan
William J. Kell
Keith Wheatley
John A. Liu Yin
Mary Frances McMullin
Helen Dignum
David Bowen
Nigel H. Russell
Show All
Source
Cite
Save
Citations (7)
1